Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
Article in Frontiers in Pharmacology (January 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication
Article in Therapeutic Drug Monitoring (October 2021)
Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products
Article in The AAPS Journal (April 2021)